Article
DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
Antiviral therapy - 1 Jan 2007
Andrei Gracíela, Fiten Pierre, Froeyen Matheus, De Clercq Erik, Opdenakker Ghislain, Snoeck Robert
Abstract excerpt
Mutations in the thymidine kinase and DNA polymerase genes of herpes simplex virus (HSV) might confer resistance to antiviral drugs, particularly in immunocompromised patients who suffer from chronic and/or disseminated lesions. The patterns of cross-resistance and neurovirulence in mice of several DNA polymerase mutants selected under pressure of foscarnet (PFA) and different acyclic nucleoside phosphonates...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
